این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Avicenna Journal of Phytomedicine، جلد ۱۳، شماره ۳، صفحات ۲۹۰-۳۰۱

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Nano-hesperetin ameliorates 6-hydroxydopamine-induced behavioral deficits and oxidative damage by up-regulating gene expression of antioxidant enzymes
چکیده انگلیسی مقاله Objective: Hesperetin (Hst) has shown several pharmacological effects. The efficacy of Hst is highly restricted in vivo due mainly to poor bioavailability. This investigation was intended to compare the influence of Hst and nano-Hst treatment on 6-hydroxydopamine (6-OHDA)-induced behavioral deficits and oxidative stress in rats.Materials and Methods: Forty-two Wistar male rats were equally assigned to 6 groups: control, 6-OHDA, Hst5, Hst10, nano-Hst5, and nano-Hst10. Treatment with Hst and nano-Hst was initiated 1 day after the intrastriatal injection of 6-OHDA and continued for 28 days. Behavioral deficits were evaluated using apomorphine-induced rotation test (AIRT), narrow beam test (NBT) and novel object recognition test (NORT), and the hippocampus and striatum were used to evaluate oxidative stress-related parameters.Results: The rats injected only with 6-OHDA showed learning and memory deficits but Hst and nano-Hst treatments improved it (p< 0.001). Compared to the control group, a marked promotion in Malondialdehyde (MDA) levels along with a marked reduction in activities and gene expression of antioxidant enzymes and reduced glutathione (GSH) levels in the hippocampus and striatum were observed in the 6-OHDA group (p< 0.01). However, administration of Hst and nano-Hst remarkably diminished MDA levels (p< 0.01), and significantly increased the activities (p< 0.01) and gene expression of antioxidant enzymes (p< 0.05) and GSH levels (p< 0.01) compared to the 6-OHDA group. In most parameters, nano-Hst has shown better therapeutic effects than Hst.Conclusion: Our findings reveal that Hst can be considered as a potential candidate for the treatment of neurodegenerative diseases and that nano-Hst may have better bioavailability.
کلیدواژه‌های انگلیسی مقاله Antioxidant Enzymes, Behavioral disorders, Nano-hesperetin, Parkinson’s disease, 6-hydroxydopamine

نویسندگان مقاله | Akbar Hajizadeh Moghaddam
Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran


| Sara Alizadeh
Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran


| Monireh Nejadi
Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran


| Seyed Reza Mokhtari Sangdehi
Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran


| Mahboobeh Zare
Faculty of Herbs, Amol University of Special Modern Technologies, Amol, Iran


| Mojtaba Ranjbar
Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran



نشانی اینترنتی https://ajp.mums.ac.ir/article_21532.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Research Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات